Cambridge Healthtech Institute Training Seminars offer real-life case studies, problems encountered and solutions applied, and extensive coverage of the basic science underlying each topic. Experienced Training Seminar instructors offer a mix of formal lectures, interactive discussions and activities to help attendees maximize their learning experiences. These immersive trainings will be of value to scientists from industry and academic research groups who are entering new fields - and to those working in supporting roles that will benefit from an in-depth briefing on a specific aspect of the industry.
MONDAY, AUGUST 21 - TUESDAY, AUGUST 22, 2017
DAY 1 - 1:00 - 5:00 PM | DAY 2 - 8:00 AM - 5:15 PM
TS1A: Introduction to Bioprocessing
This training offers a comprehensive survey of the steps needed to produce today's complex biopharmaceuticals, from early development through commercial. The seminar begins by introducing biologic drugs and the aspects of protein science that drive the progression of analytical and process steps that follows. We then step through the stages of bioprocessing, from cell line development to scaling up for commercial production. The seminar explores emerging process technologies, facility design considerations and the regulatory and quality standards that govern development. The roles of analytical methods at all stages as well as formulation and stability assessments in developing and gaining approval are also examined.
Sheila G. Magil, Ph.D., Senior Consultant, BioProcess Technology Consultants, Inc.
Frank J. Riske, Ph.D., Senior Consultant, BioProcess Technology Consultants, Inc.
TS3A: Regulatory Requirements across the Product Development Lifecycle
This course provides a comprehensive review of the Chemistry, Manufacturing and Controls (CMC) section of regulatory filings, with a focus on phase appropriate requirements. The level of detail that must be included in the filing will be discussed as well as systems and controls that must be in place in the manufacturing setting. Topics such as process development, analytical development, Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) will be discussed in the context of the stage of drug development. Regulatory strategies for navigating the path to approval will also be discussed. This course provides a broad understanding of regulatory requirements across the product development lifecycle.
Christina Vessely, Ph.D., Senior Consultant, Biologics Consulting
Wednesday, AUGUST 23 -
ThUrSDAY, AUGUST 24, 2017
DAY 1 - 8:00 AM - 6:00 PM
DAY 2 - 8:00 AM - 12:15 PM
TS6B: Introduction to Cell Culture
This 1.5-day Intro to Cell Culture Training Seminar is a lecture-based course intended for the beginner who is thinking about culturing animal cells for the first time, or for intermediate cell culturists wanting to know more about how animal cell culture works and how to improve their process. Attendees will learn about most of the critical aspects of cell culture from equipment maintenance and media selection to cell growth and cryopreservation. Participants will have ample time to ask specific questions and get worthwhile answers.
Timothy Fawcett, Ph.D., Scientific Director, BioTechnical Institute of Maryland, Inc. and Founder, BioSciConcepts
ThursDAY, AUGUST 24 -
friDAY, AUGUST 25, 2017
DAY 1 - 1:30 pM - 5:30 PM
DAY 2 - 8:30 AM - 3:30 PM
TS8C: Intro to Downstream Processing
This activity-packed course focuses on the science, technologies and strategies needed to understand and implement an effective downstream process for biological development and production. The course begins with an in-depth look at DSP design and development - from recovery to purification to formulation - before moving onto pertinent issues surrounding HTPD, single-use systems, continuous processing, PAT, viral clearance, platform development, process validation and bioprocess simulation. The course will be based on real-world examples from downstream development projects for both traditional and emerging modalities. Students will learn through on-site exercises and use of computational tools.
Jean-Francois Hamel, Ph.D., Academic Researcher and Instructor, Chemical Engineering Department, Massachusetts Institute of Technology; Biotech Programs, Northeastern University
TS9C: Introduction to Analytical Method Development and Validation for Therapeutic Proteins
This course is a panoramic review of analytical method development and validation for therapeutic proteins, including antibodies and enzymes. It starts with basic knowledge of work on therapeutic proteins: manufacturing of protein drugs, regulatory affair knowledge and protein chemistry. It then discusses fundamentals and practical aspects of commonly used analytical methods for proteins, including methods for structure elucidation, glycan characterization, biophysical characterization, potency measurement, purity and impurity analysis. The course concludes with the strategy and common practice in method validation and method transfer, including regulatory compliance at different stages of product development, application of DOE and QbD. The course emphasizes practical applications, real-world examples and useful tips.
Jichao (Jay) Kang, Ph.D., RAC, Director, Analytical and Formulation Development, Patheon Biologics
TS10C: Introduction to Biologics Formulation and Delivery
The formulation training seminar focuses on strategies to plan and execute preformulation and formulation development studies for biologics that require co-optimization of multiple physical, chemical, and conformational stability attributes under accelerated timelines to ensure rapid delivery of a stabile product to the clinic. The seminar begins with an overview of biophysical and biochemical properties of proteins and protein structure, setting the stage for the concepts at the core of protein formulation, then explores the theory and application of the relevant analytical and biophysical techniques that support preformulation and formulation development studies. The course then concludes with examination of real-world case studies.
Donald E. Kerkow, Ph.D., Associate Director, Biopharmaceutical Development, KBI Biopharma, Inc.
TS11C: Designing Flexible Facilities for Bioprocess Development and Manufacturing
Biomanufacturing organizations today are looking for best practice approaches to create flexible manufacturing assets to support overall business needs. With expanding product pipelines and the introduction of new technology platforms, creating an asset that will not only have a long lifecycle expectancy but one that will also be flexible to meet development and commercial launch needs is a paramount business goal.
This two-day course will introduce attendees to the key facility design considerations that are needed to ensure the creation of a design concept and approach that will yield highly flexible, optimized, and highly utilized manufacturing assets. Key concepts will include development and understanding of a manufacturing enterprise model, the product-process-facility paradigm, "design-to-operate" methodology, appropriateness of GMP design compliance, and the identification and mitigation of risks around a sound QRM approach.
The course will implement traditional lecture components, class exercises, and the use of case studies as learning tools.
Jeffery Odum, MSc, CPIP, Global Technology Partner, NNE Pharmaplan; Managing Partner, Strategic Manufacturing Concept Group
Training Seminar Information
Each CHI Training Seminar offers 1.5 days of instruction with start and stop times for each day shown above and on the Event-at-a-Glance published in the onsite Program & Event Guide. Training Seminars will include morning and afternoon refreshment breaks, as applicable, and lunch will be provided to all registered attendees on the full day of the class.
Each person registered specifically for the training seminar will be provided with a hard copy handbook for the seminar in which they are registered. A limited number of additional handbooks will be available for other delegates who wish to attend the seminar, but after these have been distributed, no additional books will be available.
Though CHI encourages track hopping between conference programs, we ask that Training Seminars not be disturbed once they have begun. In the interest of maintaining the highest quality learning environment for Training Seminar attendees, and because Seminars are conducted differently than conference programming, we ask that attendees commit to attending the entire program, and not engage in track hopping, as to not disturb the hands-on style instruction being offered to the other participants.